Adalimumab in patients with vision-threatening uveitis: real-world clinical experience.

Timothy Lee Tang Lee Say Verlyn YangJacob M FingretSophia ZagoraRichard SymesChristine YounanElisa Eleanor CornishNitin VermaAnthony SammelDenis WakefieldDeborah SpedenPeter J McCluskey

Published in: BMJ open ophthalmology (2021)

This study highlights the efficacy of adalimumab in patients with vision-threatening non-infectious uveitis, preserving vision and allowing reduction of corticosteroid dose.

Keyphrases

juvenile idiopathic arthritis
rheumatoid arthritis
ankylosing spondylitis
disease activity
systemic lupus erythematosus